Research article

REMDESIVIR PLUS IVERMECTIN INFLUENCE LIVER ENZYMES (ALT & AST) IN COVID-19 PATIENTS.

Enamm S. Abdullah1, Dr. Usama A. Ecabi2, Dr. Musaab Kadhim Alabbodi3 and Dr. Ibrahim Salim Abdullah4

Online First: March 14, 2023


At the end of 2019, the world is witnessing the emergency of the Covid-19 virus, which has turned into a global pandemic disease. With dangerous death rates, so many countries have begun to made special hospital for the quarantine of the infected patients, to prevent as much as possible the separation and give treatments to patients. In admission to respiratory and circulation system effects. The disease lead to damage the liver cells and used of treatments lead to more offensive the liver injury and elevated the liver enzymes. The search was done on 100 patients known case of moderate to severe Covid-19 they need in hospitalization by study the sAST &sALT at admission and after medications, then compare the results.

Keywords

Remdesivir, Ivermectin, sALT,s AST, COVID-19,WHO,RNA,SARS.